Table 1C.
Characteristics of patients whose serum was used for experiments.
| Patient ID | Degree of thymic hyperplasia (1) | Anti-AChR titer (nmol/L) |
|---|---|---|
| MG68 | High | 80 |
| MG69 | High | 7.6 |
| MG70 | High | 21.8 |
| MG71 | High | 10.9 |
| MG72 | High | 50.9 |
| MG73 | High | NS |
| MG74 | High | 16.3 |
| MG75 | High | 14.5 |
| MG76 | No hyperplasia | 0 |
| MG77 | No hyperplasia | 0 |
| MG78 | No hyperplasia | 2.27 |
| MG79 | No hyperplasia | 1.66 |
| MG80 | No hyperplasia | 3.7 |
| MG81 | No hyperplasia | 0 |
| MG82 | High | 8.7 |
| MG83 | High | 36 |
Patients are females (13), aged from 23 to 46, and males (3) aged of 18 to 37. All patients were under anticholinesterasic therapy and were corticoid-free. (1) Degree of thymic hyperplasia: low hyperplasia (with 2 or fewer GCs per section) or high hyperplasia (with 3 or more GCs per section).